119 related articles for article (PubMed ID: 5723963)
1. Growth characteristics of a mouse plasma cell tumor.
Bergsagel DE; Valeriote FA
Cancer Res; 1968 Nov; 28(11):2187-96. PubMed ID: 5723963
[No Abstract] [Full Text] [Related]
2. Chemotherapy and rate of kill of tumor cells in a mouse plasmacytoma.
Hiramoto RN; Ghanta VK
Cancer Res; 1974 Jul; 34(7):1738-42. PubMed ID: 4833918
[No Abstract] [Full Text] [Related]
3. Kinetics of stem cell depletion and proliferation: effects of vinblastine and vincristine in normal and irradiated mice.
Smith WW; Wilson SM; Fred SS
J Natl Cancer Inst; 1968 Apr; 40(4):847-54. PubMed ID: 4869136
[No Abstract] [Full Text] [Related]
4. Disseminated growth of murine plasmacytoma: similarities to multiple myeloma.
Roschke V; Hausner P; Kopantzev E; Pumphrey JG; Riminucci M; Hilbert DM; Rudikoff S
Cancer Res; 1998 Feb; 58(3):535-41. PubMed ID: 9458102
[TBL] [Abstract][Full Text] [Related]
5. [On the oncogenesia of plasmacytoma (LPC-1). Transplantable neoplasm (HIPA) with plasma cell evolution, induced by spleen homogenate from a BALB-c mouse treated with mineral oil. 1. Biology and histology].
Pedio G; Grieshaber E; Rüttner JR
Pathol Microbiol (Basel); 1968; 31(5):278-86. PubMed ID: 5687787
[No Abstract] [Full Text] [Related]
6. Transplantable mouse plasma cell tumors in experimental chemotherapy.
Teller MN; Abraham D; Bowie M; Carbone PP
J Natl Cancer Inst; 1969 Jul; 43(1):123-31. PubMed ID: 5816022
[No Abstract] [Full Text] [Related]
7. Interaction between a murine myeloma cell line and bone marrow stromal cells.
Bradley TR; Kriegler AB; Verschoor SM; Tzelepis SM; Cooper IA
Exp Hematol; 1996 Feb; 24(2):307-9. PubMed ID: 8641357
[TBL] [Abstract][Full Text] [Related]
8. Growth characteristics of MOPC-315 plasmacytoma and response to anticancer agents.
Valeriote F; Lynch R; Berger NA; White E; Coulter D
J Natl Cancer Inst; 1981 Jun; 66(6):1083-8. PubMed ID: 7017213
[TBL] [Abstract][Full Text] [Related]
9. Life history of cells mediating natural resistance to tumor cells and bone-marrow transplants: the respective roles of cell lineage commitment and host environment in determining strain characteristics of natural resistance to foreign marrow grafts.
Miller SC
Am J Anat; 1984 Jul; 170(3):367-76. PubMed ID: 6383004
[TBL] [Abstract][Full Text] [Related]
10. Effect of subcutaneously administered 2,6,10,14-tetramethylpentadecane on plasmacytoma growth.
Platica M; Bojko C; Steiner G; Hollander VP
Cancer Res; 1980 Jul; 40(7):2229-33. PubMed ID: 6248200
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of B-lymphocyte clonal proliferation by spleen cells from plasmacytoma-bearing mice.
Hamburger AW
J Natl Cancer Inst; 1980 Dec; 65(6):1337-43. PubMed ID: 6968847
[TBL] [Abstract][Full Text] [Related]
12. Mouse myeloma tumor stem cells: a primary cell culture assay.
Park CH; Bergsagel DE; McCulloch EA
J Natl Cancer Inst; 1971 Feb; 46(2):411-22. PubMed ID: 5115909
[No Abstract] [Full Text] [Related]
13. Rapid and specific targeting of 125I-labeled B lymphocyte stimulator to lymphoid tissues and B cell tumors in mice.
Riccobene TA; Miceli RC; Lincoln C; Knight Y; Meadows J; Stabin MG; Sung C
J Nucl Med; 2003 Mar; 44(3):422-33. PubMed ID: 12621010
[TBL] [Abstract][Full Text] [Related]
14. Regulation of immune responses aginst the syngeneic ADJ-PC-5 plasmacytoma in BALB-c mice. III. Induction of specific T suppressor cells to the BALB/c plasmacytoma ADJ-PC-5 during early stages of tumorigenesis.
Haubeck HD; Kölsch E
Immunology; 1982 Nov; 47(3):503-10. PubMed ID: 6215340
[TBL] [Abstract][Full Text] [Related]
15. Lewis lung carcinoma in mice as an experimental therapy model. I. The growth kinetics and the effect of tumor on host.
Budzyński W
Arch Immunol Ther Exp (Warsz); 1982; 30(5-6):363-72. PubMed ID: 7184487
[TBL] [Abstract][Full Text] [Related]
16. Increased sensitivity of a plasma cell tumour to T.E.M. on conversion to the ascitic form: relationship to karyotype and cycle kinetics.
Whisson ME; Siracký J
Neoplasma; 1969; 16(4):347-61. PubMed ID: 5344223
[No Abstract] [Full Text] [Related]
17. Effect of antithymocyte sera on the growth of plasma cell tumors in mice.
Mandel MA; DeCosse JJ
Surg Forum; 1969; 20():109-11. PubMed ID: 5383021
[No Abstract] [Full Text] [Related]
18. Experimental plasmacytoma in mice. I. Induction, morphological and biological characteristics.
Salwa J
Arch Immunol Ther Exp (Warsz); 1980; 28(1):167-72. PubMed ID: 7416920
[TBL] [Abstract][Full Text] [Related]
19. The effects of heterologous antithymocyte sera in mice. IV. Alteration of the growth rate of plasma cell tumors.
Mandel MA; DeCosse JJ
J Immunol; 1969 Dec; 103(6):1288-93. PubMed ID: 5361565
[No Abstract] [Full Text] [Related]
20. Spleen-colony cell kinetics.
Lord BI; Schofield R
J Physiol; 1968 Jul; 197(1):49P-50P. PubMed ID: 5675069
[No Abstract] [Full Text] [Related]
[Next] [New Search]
